KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Biogen (BIIB) Shares Repurchased (2016 - 2022)

Historic Shares Repurchased for Biogen (BIIB) over the last 14 years, with Q3 2022 value amounting to $250.0 million.

  • Biogen's Shares Repurchased fell 6666.67% to $250.0 million in Q3 2022 from the same period last year, while for Dec 2023 it was $250.0 million, marking a year-over-year decrease of 6666.67%. This contributed to the annual value of $750.0 million for FY2022, which is 5833.33% down from last year.
  • As of Q3 2022, Biogen's Shares Repurchased stood at $250.0 million, which was down 6666.67% from $500.0 million recorded in Q2 2022.
  • Biogen's 5-year Shares Repurchased high stood at $2.8 billion for Q2 2020, and its period low was $250.0 million during Q1 2018.
  • Over the past 5 years, Biogen's median Shares Repurchased value was $733.9 million (recorded in 2019), while the average stood at $1.2 billion.
  • Its Shares Repurchased has fluctuated over the past 5 years, first surged by 25175.24% in 2018, then crashed by 8397.95% in 2021.
  • Biogen's Shares Repurchased (Quarter) stood at $1.4 billion in 2018, then soared by 54.75% to $2.1 billion in 2019, then crashed by 80.89% to $400.0 million in 2020, then skyrocketed by 87.5% to $750.0 million in 2021, then crashed by 66.67% to $250.0 million in 2022.
  • Its Shares Repurchased stands at $250.0 million for Q3 2022, versus $500.0 million for Q2 2022 and $750.0 million for Q3 2021.